Fluorine-18-fluorodeoxyglucose positron emission tomography for assessment of patients with unresectable recurrent or metastatic lung cancers after CT-guided radiofrequency ablation: Preliminary results

Annals of Nuclear Medicine

Volumn 20, Issue 2, 2006, Pages 115-121

  Okuma, Tomohisa ^a   Okamura, Terue ^b   Matsuoka, Toshiyuki ^a   Yamamoto, Akira ^a   Oyama, Yoshimasa ^a   Toyoshima, Masami ^c   Koyama, Koichi ^a   Inoue, Kiyotoshi ^a   Nakamura, Kenji ^a   Inoue, Yuichi ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Saiseikai Nakatsu PET Center Hospital   (Japan)

^c National Hospital Organization   (Japan)

Author keywords

FDG PET; Lung cancer; Radiofrequency ablation

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER GROWTH; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; INTERMETHOD COMPARISON; LUNG CANCER; LUNG METASTASIS; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RECURRENT CANCER; TREATMENT OUTCOME; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CATHETER ABLATION; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SURGERY, COMPUTER-ASSISTED; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 33645085579     PISSN: 09147187     EISSN: 09147187     Source Type: Journal    
DOI: 10.1007/BF02985623     Document Type: Article

References (24)

1. Gazelle GS, Goldberg SN, Solbiati L, Livraghi T. Tumor ablation with radio-frequency energy. Radiology 2000; 217: 633-646.
2. Dupuy DE, Goldberg SN. Image-guided radiofrequency tumor ablation: challenges and opportunities - part 2. J Vasc Interv Radiol 2001; 12: 1135-1148.
3. Curley SA, Izzo F, Ellis LM, Nicolas VJ, Vallone P. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg 2000; 232: 381-391.
4. Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Ierace T, Solbiati L, et al. Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions. Radiology 2000; 214: 761-768.
5. Rossi S, DiStasi M, Buscarini E, Quaretti P, Garbgnati F, Squassante L, et al. Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. AJR Am J Roentgenol 1996; 167: 759-768.
6. Gervais DA, McGovern FJ, Arellano RS, McDougal WS, Mueller PR. Renal cell carcinoma: clinical experience and technical success with radio-frequency ablation of 42 tumors. Radiology 2003; 226: 417-424.
7. Rosenthal DI, Springfield DS, Gebhart MC, Rosenberg AE, Mankin HJ. Osteoid osteoma: percutaneous radio-frequency ablation. Radiology 1995; 197: 451-454.
8. Dupuy DE, Zagoria RJ, Akerley W, Mayo-Smith WW, Kavanagh PV, et al. Percutaneous radiofrequency ablation of malignancies in the lung. AJR Am J Roentgenol 2000; 174: 57-59.
9. Steinke K, Habicht JM, Thomsen S, Soler M, Jacob AL. CT-guided radiofrequency ablation of a pulmonary metastasis followed by surgical resection. Cardiovasc Intervent Radiol 2002; 25: 543-546.
10. Herrera LJ, Fernando HC, Perry Y, Gooding WE, Buenaventura PO, Christie NA, et al. Radiofrequency ablation of pulmonary tumors in nonsurgical candidates. J Thorac Cardiovasc Surg 2003; 125: 929-937.
11. Oyama M, Matsuoka T, Toyoshima M, Okuma T, Yamamoto A, Sakai Y, et al. Usefulness of computed tomography for evaluating recurrence after radiofrequency ablation. JJLC Jpn J Lung Cancer 2003; 43: 247-252.
12. Steinke K, King J, Glenn D, Morris DL. Radiologic appearance and complications of percutaneous computed tomography-guided radiofrequency-ablated pulmonary metastases from colorectal carcinoma. J Comput Assist Tomogr 2003; 27: 750-757.
13. Sewell PE, Jackson MS, Vance RB, Wang YD. Assessing radiofrequency ablation of non-small cell lung cancer with positron emission tomography (PET) [abstract]. Radiology 2000; 217 (suppl): 334.
14. Akeboshi M, Yamakado K, Nakatsuka A, Hataji O, Taguchi O, Takao M, et al. Percutaneous radiofrequency ablation of lung neoplasms: Initial therapeutic response. J Vasc Interv Radiol 2004; 15: 463-470.
15. Dupuy DE, Mayo-Smith WW, Abbott GF, DiPetrillo T. Clinical applications of radio-frequency tumor ablation in the thorax. RadioGraphics 2002; 22: S259-269.
16. Suh RD, Wallace AB, Sheehan RE, Heinze SB, Goldin JG. Unresectable pulmonary malignancies: CT-guided percutaneous radiofrequency ablation - Preliminary results. Radiology 2003; 229: 821-829.
17. Matsuoka T, Toyoshima M, Nakamura K, Yamada R, Inoue K, Lubinski A. Percutaneous radiofrequency ablation for lung tumors. Cardiovasc Intervent Radiol 2001; 24 (suppl): 202.
18. Yasui K, Kanazawa S, Sano Y, Fujiwara T, Kagawa S, Mimura H, et al. Thoracic tumors treated with CT-guided radiofrequency ablation: initial experience. Radiology 2004; 231: 850-857.
19. Nishida T, Inoue K, Kawata Y, Izumi N, Nishiyama N, Kinoshita H, et al. Percutaneous radiofrequency ablation of lung neoplasms: A minimally invasive strategy for inoperable patients. J Am Coll Surg 2002; 195: 426-430.
20. Giannopoulou C. The role of SPET and PET monitoring tumour response to therapy. Eur J Nucl Med 2003; 30: 1173-1200.
21. Lee J, Aronchick JM, Alavi A. Accuracy of F-18 Fluorodeoxyglucose positron emission tomography for the evaluation of malignancy in patients presenting with new lung abnormalities. Chest 2001; 120: 1791-1797.
22. Kostakoglu L, Goldsmith SJ. F-18-FDG PET evaluation of the response to therapy for lymphoma and for breast, lung, and colorectal carcinoma. J Nucl Med 2003; 44: 224-239.
23. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 2000; 92: 205-216.
24. Kubota K, Itoh M, Ozaki K, Ono S, Tashiro M, Yamaguchi K, et al. Advantage of delayed whole-body FDG-PET imaging for tumour detection. Eur J Nucl Med 2001; 28: 696-703.